Zurueck zur Suche

Reporte zur Charge UJ594AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 1 OH 1 NY 1 MI 1 CO 1

VAERS 2397654

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AA

mild
Staat
CA
Alter
2,0
Geschlecht
F
Eingang
30.07.2022
Impfdatum
25.07.2022
Beginn
27.07.2022
Tage bis Beginn
2,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Immunisation reaction Injection site induration Injection site inflammation

Symptomtext

7/25/22 Pt. came in for a shot only appointment and received 2 vaccines DTP on the left thigh and HIB on the right thigh . 7/27/22 Pt. came in for sick visit, Left thigh was hard and inflamed Diagnosis: Reaction to vaccine Medication: Clindamycin 75mg/5ml (10.5 ml TID x 10 days) Follow up phones calls by office

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site induration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2507993

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AA

gering
Staat
OH
Alter
1,0
Geschlecht
M
Eingang
15.11.2022
Impfdatum
31.10.2022
Beginn
31.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

the diluent for the product was expired with no reported adverse event; Initial information was received on 08-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 1 years old male patient who was reported with diluent for the product was expired with no reported adverse event while receiving vaccine hib (prp/t) vaccine [ACT-HIB]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 31-Oct-2022, the patient received suspect standard hib (prp/t) vaccine powder and solvent for solution for injection at a dose of 0.5 ml once (lot UJ594AA, expiry date - 30-Jan-2023) (diluent - Lot Number:U7171AB, Expiration Date: 26-Oct-2022) via intramuscular route in unknown administration site for Immunization. On 31-Oct-2022 the patient reported a non-serious event of the diluent for the product was expired with no reported adverse event (expired product administered) (latency: same day) following the administration of hib (prp/t) vaccine. Action taken with haemophilus type b (hib) vaccine (ACT-HIB) was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2502863

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AA

gering
Staat
NY
Alter
2,0
Geschlecht
M
Eingang
09.11.2022
Impfdatum
28.10.2022
Beginn
28.10.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

expired ACTHIB being administered to a patient with no reported adverse event; Initial information received on 28-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 years old male patient and reporter stated expired HIB (PRP/T) vaccine [ACT-HIB] being administered to a patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included INFLUENZA VACCINE (FLUZONE [INFLUENZA VACCINE]). On 28-Oct-2022, the patient received a expired 0.5 ml dose of suspect HIB (PRP/T) vaccine once ( 4th dose)(lot UJ594AA and expiry date 26-OCT-2022)(strength : standard) via intramuscular route in the left arm as Immunization, with no reported adverse event (expired product administered)(latency: same day). Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
FLUZONE [INFLUENZA VACCINE]
Allergien
-
Vorherige Impfungen
-

VAERS 2473393

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AA

gering
Staat
MI
Alter
1,1
Geschlecht
F
Eingang
10.10.2022
Impfdatum
10.10.2022
Beginn
10.10.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Patient was given the wrong dose of Influenza . She s/h/b given the 0.25mg. This was her first influenza vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2440265

SANOFI PASTEUR · HIB (ACTHIB) · Charge UJ594AA

gering
Staat
CO
Alter
1,3
Geschlecht
F
Eingang
12.09.2022
Impfdatum
23.08.2022
Beginn
23.08.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation error

Symptomtext

ACTHIB was administered using a sterile water diluent instead of the provided diluent with no reported adverse event; Initial information regarding an unsolicited valid non-serious case received from health professional on 24-Aug-2022. This case involves a 15-month-old female patient who was administered vaccine HIB (PRP/T) VACCINE [ACT-HIB] using a sterile water diluent instead of the provided diluent with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pneumococcal Vaccine CONJ 13V (CRM197) (Prevnar 13) for Immunization. On 23-Aug-2022, the patient received 4th dose of suspect ACT-HIB vaccine at dose 0.5ml once (lot UJ594AA) via intramuscular route in the left thigh for prophylactic vaccination administered using a sterile water diluent instead of the provided diluent with no reported adverse event (product preparation error) same day latency. Action taken: Not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PREVNAR 13
Allergien
-
Vorherige Impfungen
-